ABSTRACT
The response to vaccination is not only a health problem and its epidemiological characterization cannot only respond to an exclusively biomedical perspective but also to social, educational and economic scopes with deep cultural roots. The objective of this study was to know the attitudes and beliefs in four indigenous communities of the Cotopaxi province, regarding the vaccination process. The results of the sampled were stratified in order to explore whether indigenous communities with a higher educational level or greater attendance at educational talks on vaccination differed from others in terms of their attitudes and erroneous beliefs about this process. The Zq1 community proved to be the one with the lowest educational level, the lowest percentage of attendance at educational talks and had the highest percentage of acceptance of vaccination (75.0%). The median rate of erroneous beliefs was higher for beliefs such as "Vaccines are not safe" (Aq3, Cq4: 9.4 +or- 1.1, Gq2: 9.3 +or- 1.2, Zq1: 8.8 +or- 1.3) and "Vaccines have a hidden purpose" (Aq3: 8.6 +or- 1.5, Cq4: 8.7 +or- 1.4, Gq2: 9.0 +or- 1.3, Zq1: 8.4 +or- 1, 8).
ABSTRACT
Since the discovery of the new betacoronavirus, SARS-Cov-2, the description of skin lesions, considered an essential diagnostic and prognostic factor was initiated to anticipate the level of risk and severity of the dermatological sequelae that a person can manifest when suffering from Covid-19. Due to international initiatives, a vaccine against this disease was obtained in record time. However, the vaccines have presented side effects different from those predicted in preclinical phases, without meaning that they are defective since this is expected behavior. Reports made after the licensing of the Pfizer and Moderna vaccines ratify the data presented in their respective clinical studies in which they indicate that the most frequent adverse cutaneous events are localized reactions. The present article describes the cutaneous reactions that developed when administering the vaccine against Covid-19 to facilitate its diagnosis.
ABSTRACT
At the beginning of January 2020, the World Health Organization-WHO named SARS-CoV-2 a new virus discovered in Wuhan, China at the end of 2019 and that causes COVID-19. The disease spread rapidly throughout the city and spread to the country and the rest of the world, causing it to be declared a pandemic in March 2020. With this announcement, the entire world was affected by the restrictions that several countries implemented in order to stop the rate of infection. As the disease is being investigated and better characterized, several symptoms have been recorded that can be attributed to previous infection with this virus. This is the case of telogen effluvium, which has been characterized as a sequel to COVID-19, occurring an average of 1.5 months after the initial infection. This work will describe telogen effluvium as a pathology, its clinical manifestations and possible causes, taking into account into account its role as a new sequel described for the COVID-19 disease.